Moderator
Gerallt Williams
Aptar Pharma
Aptar Pharma
CONVERSATIONS WITH WORKSHOP PRESENTERS
Thursday • May 6, 2021
5:15–6:15 pm CET
Thursday • May 6, 2021
5:15–6:15 pm CET
Live Breakout Sessions with Workshop Presenters
Review the on-demand workshop presentations, then join our Workshop Presenters in their Breakout Rooms for live Q&A
Next Generation Of Low CO2 Footprint Inhalers - How Can We Manage The Transition Together?
Chris Baron and Segolene Sarrailh
Inhalation and Nasal Delivery: Fully Integrated Dry Powder Solutions
Beatriz Fernandes and João Pereira
Breaking Down Barriers to Complex Formulation Challenges with Next Generation DPI and MDI Technology
Louise Righton and Stephen Stein
Biorelevant Aerosol Testing and Modeling for Respiratory Drug Delivery
Jimmy Beaty and Cameron Kadleck
Novel Patient-centric Solutions for Mono-dose Capsule-based DPIs to Bring a Better Patient Experience and Environmental Impact
Marco Franza and Mauro Citterio
Putting the Patient First: Using Innovation and Patient Interfacing to Provide Safe, Cost-Efficient Drug Delivery through Improved Product and Processes
Thorsten Lehmann and Anselm Ebert
Development of a Generic Dry Powder Inhaler Platform for a Global Market
Orest Lastow
Manufacturing DPIs: An Engineering Perspective
Alessio Tarozzi and Mathieu Pfeiffer
HFA-152a From The Laboratory To Commercial Production – A Practical Guide
Stuart Corr and Paul Watkinson
How To Design The Optimal Capsule For Your DPI Project
FBJulien Lamps and Frédérique Bordes-Picard
Key Success Factors for Bioequivalence Nasal Spray Development
PF
Pascale Farjas and Alain Regard
Greening Up Our Act To Secure Supply: Supporting Pharma To Move Towards More Environmentally Friendly Propellants
Lei Mao and Mark Knowles
Inhaled Bioequivalence: A Broader View Of Product Development
Martin Oliver, Andreas Meliniotis, Tina Hart and Bradley Morrical
